1315 Capital II L.P. insider trades
Open-market stock purchases and sales by 1315 Capital II L.P., 10% Owner at Interpace Biosciences, Inc, from SEC Form 4 filings since Oct 11, 2024.
Companies traded
- IDXG Interpace Biosciences, Inc: other filings, last Jan 20, 2026
Get free alerts when 1315 Capital II L.P. files a new trade →